Lecture 8-12 (Textbook+note version) Flashcards

1
Q

———-make up a small but important group of neurotransmitters and hormones called catecholamines. The term catecholamine is derived from the fact that the members
of this group all share two chemical similarities: —-

A
  • DA, NE, and the related substance epinephrine (EPI)
  • a core structure of catechol and a nitrogen-containing group called an amine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

monoamines (4)

A

Dopamine + Norepinephrine + Epinephrine + Serotonine

transmitters that possess one amine group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The adrenal medulla secretes —– into the bloodstream, where they act as —–. You will recall from Chapter 3 that stimulation of catecholamine secretion from the adrenal glands is a vital part of the physiological response to —-.

A
  • EPI and NE
  • hormones
  • stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hormone vs Neurotransmitter

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The synthesis of catecholamine neurotransmitters occurs in several steps:

A
  1. The biochemical pathway begins with the amino acid tyrosine. Like other amino acids, tyrosine is obtained from dietary protein and is transported from the blood into the brain.
  2. Neurons that use DA as their transmitter contain only the first two enzymes, tyrosine hydroxylase (TH) and aromatic
    amino acid decarboxylase (AADC), and thus the biochemical pathway stops at DA
  3. In contrast, neurons that need to synthesize NE also possess the third enzyme, which is called dopamine β-hydroxylase (DBH).
  4. The conversion of tyrosine to dihydroxyphenylalanine (DOPA) by TH occurs at a slower rate than subsequent reactions in the biochemical pathway. Consequently, TH is the rate-limiting enzyme in the pathway because it determines the overall rate of DA or NE formation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The activity of TH is regulated by a variety of factors, including how much DA or NE is present within the nerve terminal. High catecholamine levels tend to —- TH, thus serving as a negative feedback mechanism. Another important factor is the rate of cell firing, because neuronal activity has a —– effect on TH. The mechanism by which cell firing stimulates TH activity is through phosphorylation of the enzyme.

A
  • inhibit
  • stimulatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

These elegant mechanisms of phosphorylation activation and catecholamine feedback inhibition enable dopaminergic and noradrenergic neurons to carefully control their rate of neurotransmitter formation. When the levels are too high, —- is inhibited and catecholamine synthesis is slowed. But when the neurons are activated and firing at a high rate, such as during stress, —- is stimulated and catecholamine synthesis accelerates to keep up with the increased demand.

A
  • TH
  • TH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Although the enzymes involved in synthesizing catecholamines
(as well as other classical transmitters like acetylcholine and serotonin) can be found throughout the neurons using those transmitters, the rate of synthesis is greatest at the ——.

A

nerve endings near the sites of transmitter release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Role of l-DOPA

A
  • Catecholamine formation can be increased by
    the administration of biochemical precursors such as
    tyrosine and l-DOPA. Furthermore, certain cognitive
    functions such as working memory can be modestly
    but measurably enhanced by tyrosine administration
    under conditions of high cognitive demand or stress
    (reviewed by Hase et al., 2015; Jongkees et al., 2015).
  • Such enhancement is thought to occur because dopaminergic and noradrenergic neurons are activated under
    the aforementioned conditions, and therefore tyrosine
    supplementation provides the necessary substrate to
    keep up with the demand for increased neurotransmitter synthesis.
  • Dopamine cannot cross blood-brain but L-DOPA can (give to make more dopamine), used to give with Carbidopa to prevent L.Dopa from being converted to something else.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vescular packagig is important because (2)

A

Vesicular packaging is important not only because it provides a means of releasing a predetermined amount of neurotransmitter (usually several thousand molecules per vesicle), but also because it protects the neurotransmitter from degradation by enzymes within the nerve terminal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vesicular monoamine transporter (VMAT) (3)

What + type + blocked by

A
  • A specific protein in the vesicle membrane is responsible for vesicular catecholamine uptake. This protein recognizes several different monoamine transmitters and therefore is called the vesicular monoamine transporter (VMAT).
  • There are actually two related VMATs: VMAT1 is found in the adrenal medulla, whereas VMAT2 is present in the brain.
  • Both of these vesicular transporters are blocked by an
    interesting drug called reserpine, which comes from the roots of the plant Rauwolfia serpentina (snake root)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blocking the vesicular transporter means that —-. As a result, both transmitters temporarily —— in the brain. The behavioral consequence of this neurochemical effect is sedation in animals and depressive symptoms in humans.

A
  • DA and NE are no longer protected from breakdown within the nerve terminal
  • drop to very low levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The sedative effects of reserpine could be reversed by restoration of catecholamines with —–, the —–

A
  • DOPA
  • immediate biochemical precursor of DA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Release of catecholamines normally occurs when ——-. Certain drugs, however, can cause a release of catecholamines independently: —–

A
  1. a nerve impulse enters the terminal and triggers one or more vesicles to release their contents into the synaptic cleft through the process of exocytosis
  2. The psychostimulants amphetamine and methamphetamine. In humans, amphetamine and methamphetamine produce increased alertness, heightened energy, euphoria, insomnia, and other behavioral effects. They interact with VMAT to cause release of neurotransmitter into synapse and block reuptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In contrast to the behavioral sedation associated with reserpine-induced catecholamine depletion, catecholamine release leads to ——. In laboratory animals such as rats and mice, this activation may be shown by increased locomotor activity. At high doses, locomotor activation is replaced by stereotyped behaviors consisting of intense sniffing, repetitive head and limb movements, and licking and biting.

A
  • behavioral activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain how catecholamine is inhibited (2):

by what + through 2 combined mechanism

A
  • Catecholamine release is inhibited by autoreceptors (DA autoreceptor is of the D2 receptor subtype) located on the cell bodies, terminals, and dendrites of dopaminergic and noradrenergic neurons through G-protein coupled inhibition
  • Current evidence indicates that at least in the case of DA, these autoreceptors inhibit neurotransmitter release through two combined mechanisms: (1) by inhibiting the action of voltage-gated Ca2+ channels in the nerve terminal membrane and (2) by enhancing the opening of a specific type of voltage gated K+ channel in the terminal. The first mechanism would reduce DA release by directly reducing the amount of activity-mediated Ca2+ influx needed for vesicular exocytosis, whereas the second mechanism could indirectly reduce Ca2+ influx
    by shortening the duration of action potentials entering the terminal.
17
Q

if a dopaminergic cell fires several action potentials in a row, we can imagine that DA released by the first few impulses stimulates the terminal —- and reduces the amount of DA released by the later action potentials.

A
  • autoreceptors
18
Q

Firing pattern of the neuron is yet another factor that influences catecholamine release. This has
been studied extensively in midbrain dopaminergic
neurons, which fire in two different patterns. In single-spiking mode, the cell generates action potentials
(“spikes”) that appear at —- intervals but with
a typical average frequency of 4 to 5 Hz (4–5 spikes
per second). Excitatory input to the cell can switch it
from single-spiking mode to — mode, which is
characterized by trains of 2 to 20 spikes at a frequency of approximately 20 Hz. The difference between
these firing modes can be seen in firing patterns of dopaminergic neurons within the ventral tegmental area (VTA) in a rat under conditions of quiet wakefulness,
slow-wave sleep, rapid-eye-movement (REM) sleep,
and feeding: —– can be seen during REM sleep
and feeding, which is the result of —–. DA released when the cell is in single-spiking mode is often called —- release,
whereas DA released in burst mode is called —-
release.

A
  • irregular
  • burst
  • Burst firing
  • greater dopaminergic neuronal activation
  • tonic
  • phasic
19
Q

Importantly, the extracellular level of DA in areas of release following a burst of spikes is —- than would be expected from the number of spikes in the burst, mainly because —–

A
  • greater
  • release of neurotransmitter is occurring faster than it can be cleared and/or metabolized
20
Q

Catecholamine inactivation occurs through the combination of reuptake and metabolism: Reuptake

A
  1. Reuptake:
    Much of the released DA and NE is taken up again into the nerve terminal by means of specific transporter proteins in the presynaptic nerve cell membrane. That is, dopaminergic neurons contain a DA transporter, whereas noradrenergic neurons contain a slightly different protein that is logically called the NE transporter. After the neurotransmitter molecules are returned to the terminal, some of them are repackaged into vesicles for rerelease, and the remainder are broken down and eliminated.
21
Q

Since the transporters are necessary for clearance of released catecholamines from the extracellular fluid, transporter blocking drugs enhance DA or NE transmission by ——-

A

increasing the amount of neurotransmitter available to activate the receptors for these transmitters.

22
Q

Tricyclic antidepressants/ Cocaine

A
  • inhibit the reuptake of all monoamines
23
Q

Catecholamine inactivation occurs through the combination of reuptake and metabolism: Metabolism

A
  1. Although reuptake can quickly terminate the
    synaptic actions of catecholamines, there must also
    be processes of metabolic breakdown to prevent excessive neurotransmitter accumulation. The breakdown of catecholamines primarily involves two enzymes: catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). NE is metabolized primarily by MAO-A in both humans
    and rodents, whereas DA is metabolized primarily by
    MAO-B in humans and by MAO-A in rodents. Although COMT doesn’t have two distinctly different forms of the enzyme like MAO, researchers have found variation in the COMT gene that causes individuals to have varying rates of DA metabolism
24
Q

If metabolizing enzymes are inhibited, NT levels will —–

A

Increase!

25
Q

MAO inhibitors

A
  • used in the treatment of clinical depression
26
Q

COMT inhibitors

A
  • are administered as supplemental therapies to enhance the effectiveness of l-DOPA in treating Parkinson’s disease. This is done not so much to prevent the metabolism of DA but rather to block the metabolism of l-DOPA by COMT before the precursor reaches the brain
27
Q

In the early 1960s, Swedish researchers first began to
map the location of DA- and NE-containing nerve cells
and fibers in the brain using a fluorescence method
(Dahlström and Fuxe, 1964). They developed a classification system in which the catecholamine cell groups
(clusters of neurons that stained for either DA or NE)
were designated with the letter A plus a number from
1 to 16. According to this system, cell groups A1 to
A7 are ——, whereas groups A8 to A16 are
——.

A
  • noradrenergic
  • dopaminergic
28
Q

Ascending dopamine pathways: nigrostriatal pathway (2)

location + role + cell number

A
  • Axons of dopaminergic neurons in the substantia nigra ascend to a forebrain structure known as the caudate–putamen or dorsal striatum.
  • motor function + reward + associative leaning/operant learning
  • A9
29
Q

Ascending dopamine pathways: mesolimbic dopamine pathway

location + role + cell number

A
  • Some of the axons from these neurons travel to various structures of the limbic system, including the nucleus accumbens (the major component of the ventral striatum), septum, amygdala, and hippocampus.
  • locomotor behaviour, reward
  • A10
30
Q

Ascending dopamine pathways: mesocortical
dopamine pathway

location + role + cell number

A
  • Other DA-containing fibers from the VTA go to the cerebral cortex, particularly the prefrontal cortex (PFC).
  • Addiction + executive functions
  • A10
31
Q

In the early stages of research on DA receptors, investigators discovered that D1 and D2 have opposite effects on the second-messenger substance cyclic adenosine monophosphate (cAMP):

A

D1 receptors stimulate the enzyme adenylyl cyclase, which is responsible for synthesizing cAMP (see Chapter 3). Consequently, the rate of cAMP formation is increased by stimulation of D1 receptors. In contrast, D2 receptor activation inhibits adenylyl cyclase, thereby decreasing the rate of cAMP synthesis. These opposing effects can occur because the receptors activate two different G proteins: Gs in the case of D1 receptors, and Gi in the case of D2 receptors

32
Q

The most commonly used agonist for —– is a compound known as SKF 38393. Administration of this compound to rats or mice elicits ——. Quinpirole is a drug that activates D2 and D3 receptors, and its effect is to —–

A
  • D1 receptors
  • self-grooming behavior
  • increase locomotion and sniffing behavior.
33
Q

haloperidol

A

Catalepsy is usually associated with D2 receptor blockers such as haloperido

34
Q

locus coeruleus (LC)

location + number

A
  • the LC sends fibers to almost all areas of the forebrain, thereby providing nearly all of the NE in the cortex, limbic system, thalamus, and hypothalamus (FIGURE 5.15). The LC also provides noradrenergic input to the cerebellum and the spinal cord.
  • a small area of the pons that contains a dense collection of noradrenergic neurons corresponding roughly to the A6 cell group (according to the numbering system described previously).
35
Q

b 1,2 and a 1,2 receptors (Adrenergic)

A

Like dopamine D1 receptors, both β1- and β2-
adrenoceptors stimulate adenylyl cyclase and enhance the formation of cAMP. In contrast, α2-receptors
operate in a manner similar to that of D2 receptors.
That is, α2-receptors reduce the rate of cAMP synthesis
by inhibiting adenylyl cyclase, and they can also cause
hyperpolarization of the cell membrane by increasing
K+ channel opening. Yet another kind of mechanism is
used by receptors of the α1 subtype. These receptors operate through the phosphoinositide second-messenger
system, which, as we saw in Chapter 3, leads to an increased concentration of free calcium (Ca2+) ions within
the postsynaptic cell.